| Literature DB >> 33815493 |
Khlood S Abou Melha1, Gamil A Al-Hazmi1,2, Ismail Althagafi3, Arwa Alharbi3, Ali A Keshk4, Fathy Shaaban5,6, Nashwa El-Metwaly3,7.
Abstract
The newly synthesized Schiff's base derivative, N-allyl-2-(2-oxoacenaphthylen-1(2H)-ylidene)hydrazine-1-carbothioamide, has been characterized by different spectral techniques. Its reaction with Co(II), Ni(II), and Zn(II) acetate led to the formation of 1 : 1 (M:L) complexes. The IR and NMR spectral data revealed keto-thione form for the free ligand. On chelation with Co(II) and Ni(II), it behaved as mononegative and neutral tridentate via O, N1, and S donors, respectively, while it showed neutral bidentate mode via O and N1 atoms with Zn(II). The electronic spectra indicated that all the isolated complexes have an octahedral structure. The thermal gravimetric analyses confirmed the suggested formula and the presence of coordinated water molecules. The XRD pattern of the metal complexes showed that both Co(II) and Ni(II) have amorphous nature, while Zn(II) complex has monoclinic crystallinity with an average size of 9.10 nm. DFT modeling of the ligand and complexes supported the proposed structures. The calculated HOMO-LUMO energy gap, ΔEH-L, of the ligand complexes was 1.96-2.49 eV range where HAAT < Zn(II) < Ni(II) < Co(II). The antioxidant activity investigation showed that the ligand and Zn(II) complex have high activity than other complexes, 88.5 and 88.6%, respectively. Accordingly, the antitumor activity of isolated compounds was examined against the hepatocellular carcinoma cell line (HepG2), where both HAAT and Zn(II) complex exhibited very strong activity, IC50 6.45 ± 0.25 and 6.39 ± 0.18 μM, respectively.Entities:
Year: 2021 PMID: 33815493 PMCID: PMC8012121 DOI: 10.1155/2021/6674394
Source DB: PubMed Journal: Bioinorg Chem Appl Impact factor: 7.778
Analytical and physical data of HAAT and its complexes.
| Compound (mol. formula; Wt.) | Color | m.p. (°C) | Elemental analyses; found (calcd.) | Λm | |||
|---|---|---|---|---|---|---|---|
| C | H | N | M | ||||
| HAAT (C16H13N3OS; 295.36) | Orange | 195 | 65.22 (65.07) | 4.64 (4.44) | 14.08 (14.23) | — | — |
| [Co(AAT) (OAc) (EtOH)] (C20H21N3O4SCo; 458.40) | Dark brown | 210 | 52.12 (52.40) | 4.38 (4.62) | 8.97 (9.17) | 12.73 (12.86) | 9.8 |
| [Ni(HAAT) (OAc)2(H2O)] (C20H21N3O6SNi; 490.16) | Brown | 220 | 48.74 (49.01) | 4.11 (4.32) | 8.33 (8.57) | 12.01 (11.97) | 10.2 |
| [Zn(HAAT) (OAc)2] (C20H19N3O5SZn; 478.38) | Brownish yellow | 230 | 49.93 (50.17) | 3.89 (4.00) | 8.45 (8.78) | 13.39 (13.65) | 10.3 |
Measured in DMSO Ω−1·cm2·mol−1.
Figure 1Structure of HAAT.
Infrared spectral date of HAAT and its metal complexes.
| Vibration | HAAT | Complexes | ||
|---|---|---|---|---|
| Ni(II) | Co(II) | Zn(II) | ||
|
|
| 3420 | 3425 | — |
|
| 3320 | 3336 | 3314 | 3323 |
|
| 3265 | 3279 | — | 3264 |
|
| 3048, 2955 | 3070, 2955 | 3060, 2957 | 3050, 2958 |
|
| 3029, 2969 | 3020, 2922 | 3030, 2918 | 3018, 2920 |
|
| — | 1702, 1390 | 1725, 1586 | 1722, 1568 |
|
| 1688 | 1652 | 1703 | 1677 |
|
| 1640 | 1619 | 1664 | 1656 |
|
| 1607 | 1602 | 1601 | 1604 |
| Thioamide I | 1525 | 1520 | 1513 | 1524 |
| Thioamide II | 1453 | 1466 | 1467 | 1451 |
| Thioamide III | 1275 | 1251 | 1234 | 1250 |
|
| 1146 | 1172 | 1117 | 1175 |
|
| 1052 | 1092 | 1080 | 1083 |
|
| 936 | 930 | 890 (C-S) | 935 |
|
| 794 | 775 | 775 | 775 |
|
| — | 528, 500 | 530, 494 | 526, 492 |
|
| — | 477 | 478 | 482 |
Figure 2Suggested structure of Co(II) complex.
Figure 3Suggested structure of Ni(II) complex.
Figure 4Suggested structure of Zn(II) complex.
Figure 51H NMR spectra of HAAT (a) and Zn(II) complex (b) in DMSO-d6.
Figure 6Mass spectrum of HAAT.
Scheme 1Fragmentation pattern of HAAT.
Electronic spectral date of AATH and its metal complexes.
| Compound | Transitions |
|
|---|---|---|
| HAAT | 35460 ( | — |
| [Co(AAT) (OAc) (H2O)] | 34970 ( | 5.00 |
| [Ni(HAAT) (OAc)2(H2O)] | 34965 ( | 3.09 |
| [Zn(HAAT) (OAc)2] | 35210 ( | — |
Thermal gravimetric analysis of HAAT and its complexes.
| Compound | Temp. range (°C) | Wt. loss % | Fragment lost | |
|---|---|---|---|---|
| Found | Calcd. | |||
| HAAT | 150–380 | 34.44 | 34.25 | HCNS + CH3CH=CH2 |
| 380–715 | 61.35 | 61.63 | C11H6N2O | |
| Residue | 4.21 | 4.12 | Carbon ash | |
|
| ||||
| [Co(AAT) (OAc) (H2O)] | 180–445 | 22.56 | 22.93 | OAc + EtOH |
| 445–620 | 60.93 | 60.73 | C16H12N3S | |
| Residue | 16.51 | 16.35 | CoO | |
|
| ||||
| [Ni(HAAT) (OAc)2(H2O)] | 155–390 | 28.01 | 27.75 | (OAc)2 + H2O |
| 390–455 | 11.68 | 11.44 | C3H6N | |
| 455–640 | 45.28 | 45.56 | C13H7N2OS | |
| Residue | 15.03 | 15.24 | NiO | |
|
| ||||
| [Zn(HAAT) (OAc)2] | 125–365 | 24.87 | 24.62 | (OAc)2 |
| 365–620 | 58.29 | 58.4 | C16H13N3OS | |
| Residue | 16.84 | 16.99 | ZnO | |
Figure 7Powder XRD pattern of Zn(II) complex.
Powder X-ray data of Zn(II) complex.
| 2 |
|
|
|
|
|
|
|---|---|---|---|---|---|---|
| 6.99 | 400 | 0.76 | 12.63 | 10.48 | 54.23 | 9.10 |
| 11.90 | −403 | 1.91 | 7.43 | 4.19 | 79.77 | 56.95 |
| 15.65 | −803 | 1.10 | 5.66 | 7.29 | 34.89 | 18.79 |
| 17.39 | 802 | 1.90 | 5.10 | 4.22 | 54.31 | 56.14 |
| 20.18 | 803 | 0.53 | 4.40 | 15.24 | 12.98 | 4.31 |
| 22.09 | 220 | 0.96 | 4.02 | 8.46 | 21.37 | 13.96 |
| 24.31 | 210 | 0.72 | 3.66 | 11.31 | 14.55 | 7.82 |
| 31.34 | 100 | 0.50 | 2.85 | 16.34 | 7.85 | 3.75 |
| 41.84 | 305 | 1.95 | 2.16 | 4.35 | 22.29 | 52.78 |
|
| — |
|
|
|
|
|
Figure 8Tauc's plots of HAAT (a) and Ni(II) complex (b).
The HOMO energy (EH), LUMO energy (EL), energy gap (ΔEH-L), electronegativity (χ), global hardness (η), softness (δ), electrophilicity (ω), and optical band gap (E) of the ligand and metal complexes in eV.
| Compound | EH | EL | ΔEH-L |
| Η |
|
|
|
|---|---|---|---|---|---|---|---|---|
| HAAT | −6.07 | −4.11 | 1.96 | 5.09 | 0.98 | 1.02 | 13.25 | 2.56 |
| Co(II) | −6.53 | −4.04 | 2.49 | 5.29 | 1.25 | 0.80 | 11.21 | 2.74 |
| Ni(II) | −6.15 | −4.02 | 2.13 | 5.08 | 1.06 | 0.94 | 12.15 | 2.18 |
| Zn(II) | −6.01 | −3.98 | 2.03 | 5.00 | 1.02 | 0.98 | 12.30 | 2.39 |
Figure 9DFT optimized structures of HAAT (a) and Co(II) (b), Ni(II) (c), and Zn(II) (d) complexes.
Figure 10The 3D plots of the investigated compound HOMO and LUMO orbitals.
ABTS antioxidant assay and in vitro cytotoxicity against HepG2 cell line of the ligand and its complexes.
| ABTS assay | In vitro cytotoxicity HePG2 | |||
|---|---|---|---|---|
| Compounds | Inhibition % | Compounds | IC50 ( | SI |
|
| 88.8 |
| 4.50 ± 0.2 | 3.28 |
|
| 88.4 |
| 6.45 ± 0.25 | 1.14 |
|
| 65.3 |
| 67.31 ± 1.35 | 0.82 |
|
| 81.4 |
| 21.46 ± 0.72 | 0.93 |
|
| 88.6 |
| 6.39 ± 0.18 | 1.28 |
IC50: 1–10 (very strong), 11–20 (strong), 21–50 (moderate), 51–100 (weak), and above 100 (noncytotoxic).
Figure 11Antioxidant (Inhibition %) and antitumor (IC50) activities of HAAT and its complexes.
Figure 12In vitro cytotoxic activities of HAAT and its complexes compared with the standard doxorubicin against HepG2cell line.